Old Web
English
Sign In
Acemap
>
authorDetail
>
Humra Shah
Humra Shah
Immunology
Progression-free survival
Medicine
Performance status
Thalidomide
2
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Rituximab and CODOX-M / IVAC Without Stem Cell Transplantation For Poor Risk Diffuse Large B Cell Lymphoma (IPI3-5) and Burkitts Lymphoma Is Feasible and Gives a High Response Rate: Preliminary Results Of a Phase 2 UK National Cancer Research Institute Trial
2013
Blood
Andrew McMillan
Kirit M Ardeshna
Jo Gambell
Andrew Jack
Amy A Kirkwood
Anthony Laurie
Silvia Montoto
Shankaranarayana Paneesha
Simon Rule
Russell Patmore
Ruth Pettengell
Humra Shah
Paul Smith
David C. Linch
Show All
Source
Cite
Save
Citations (3)
A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671
2012
Blood
W Townsend
Roderick J. Johnson
Nicholas Counsell
Humra Shah
Bryson T. Pottinger
Katy Evans
Caroline Wickham
Paul Smith
Rudin Claudius
Show All
Source
Cite
Save
Citations (0)
1